| Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives |
70 |
| The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach |
27 |
| The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions |
20 |
| The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders |
20 |
| Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives |
18 |
| Principles of OCTA and Applications in Clinical Neurology |
18 |
| Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors |
17 |
| GBA-Associated Parkinson's Disease and Other Synucleinopathies |
16 |
| Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy |
16 |
| Wearable Sensors to Monitor, Enable Feedback, and Measure Outcomes of Activity and Practice |
16 |
| Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management |
16 |
| Defining Cognitive Reserve and Implications for Cognitive Aging |
15 |
| The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews |
15 |
| Cannabis for the Treatment of Epilepsy: an Update |
15 |
| Congenital Myasthenic Syndromes in 2018 |
14 |
| Mild Cognitive Impairment in Parkinson's Disease-What Is It? |
13 |
| Aphasia Recovery: When, How and Who to Treat? |
13 |
| Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography |
13 |
| Genetic Disorders of Manganese Metabolism |
12 |
| Septic Encephalopathy |
12 |
| Update on Restless Legs Syndrome: from Mechanisms to Treatment |
12 |
| Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes |
12 |
| Managing Gait, Balance, and Posture in Parkinson's Disease |
12 |
| Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis |
11 |
| New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease |
11 |
| The Potential of Stem Cells in Treatment of Traumatic Brain Injury |
11 |
| Does Dexmedetomidine Ameliorate Postoperative Cognitive Dysfunction? A Brief Review of the Recent Literature |
10 |
| Minimally Invasive Surgery for Intracerebral Hemorrhage |
10 |
| Progressive Supranuclear Palsy: an Update |
10 |
| Infantile Spasms-Have We Made Progress? |
10 |
| Update on the Genetics of Spastic Paraplegias |
10 |
| Sleep-Wake Disorders in StrokeIncreased Stroke Risk and Deteriorated Recovery? An Evaluation on the Necessity for Prevention and Treatment |
9 |
| A Precision Medicine Approach to Cerebral Edema and Intracranial Hypertension after Severe Traumatic Brain Injury: Quo Vadis? |
9 |
| Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke |
9 |
| Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease |
9 |
| Management of Brain Metastases in the New Era of Checkpoint Inhibition |
8 |
| Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management |
8 |
| Neurologic Consequences of Preterm Birth |
8 |
| Cerebral Venous Thrombosis: an Update |
8 |
| Relation Between Stress Granules and Cytoplasmic Protein Aggregates Linked to Neurodegenerative Diseases |
8 |
| Sleep Disturbance and Cognitive Dysfunction in Multiple Sclerosis: a Systematic Review |
8 |
| Early Brain Injury After Poor-Grade Subarachnoid Hemorrhage |
7 |
| Regulation of Ion Channels by MicroRNAs and the Implication for Epilepsy |
7 |
| Takotsubo Syndrome: Clinical Features, Pathogenesis, Treatment, and Relationship with Cerebrovascular Diseases |
7 |
| Update on KMT2B-Related Dystonia |
7 |
| An Up to Date Review of Pseudotumor Cerebri Syndrome |
7 |
| Liquid Biopsy in Primary Brain Tumors: Looking for Stardust! |
7 |
| Should We Care About Early Post-Stroke Rehabilitation? Not Yet, but Soon |
7 |
| Behcet's Syndrome and Nervous System Involvement |
7 |
| Structural Imaging in Parkinson's Disease: New Developments |
7 |
